Announcements Trials

Browse Landscape

Phase

Status

Unknown 6 Completed 3 Recruiting 2 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

pembrolizumab 223 Cyclophosphamide 192 Radiotherapy 184 Nivolumab 180 Carboplatin 153 Cisplatin 114 Paclitaxel 112 Dexamethasone 111 Radiosurgery 103 Magnetic Resonance Spectroscopy 97 Surveys and Questionnaires 90 Ipilimumab 81 Doxorubicin 79 Lenalidomide 76 Rituximab 75 durvalumab 74 Radiation 73 atezolizumab 72 venetoclax 68 fludarabine 68 Gemcitabine 68 Standard of Care 67 Specimen Handling 65 Etoposide 64 Capecitabine 64 Bevacizumab 62 Oxaliplatin 59 Docetaxel 58 Biopsy 58 Radiotherapy, Intensity-Modulated 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × Lamivudine × Clear all

NCT06494579 2025-12-16

Lamivudine for Solid Tumors

Icahn School of Medicine at Mount Sinai

Phase 1/2 Active not recruiting

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡